| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | — | — |
| R&D Expense | $9.0M | +28.2% | +14.5% |
| SG&A Expense | $3.7M | +35.6% | +6.6% |
| Operating Income | -$12.7M | -30.3% | -12.1% |
| Net Income | $45.4M | +549.3% | +539.1% |
| EPS (Basic) | $0.50 | +145.9% | +144.6% |
| EPS (Diluted) | -$0.21 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.4M | +696.9% | +220.8% |
| Short-term Investments | $81.5M | +3929.8% | +283.7% |
| Current Assets | $113.3M | +1117.0% | +248.1% |
| Total Assets | $183.4M | +508.9% | +241.0% |
| Current Liabilities | $10.8M | +1.1% | +22.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$28.0M | — | — |
| Capital Expenditures | $282K | — | — |
| Investing Cash Flow | -$120.0M | — | — |
| Financing Cash Flow | $168.3M | — | — |
| Free Cash Flow | -$28.3M | — | — |
| +81.3% |
| $18.4M |
| +1.4% |
| +8.8% |
| Stockholders' Equity | $165.1M | +1273.8% | +347.3% |